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DNA-dependent protein kinase (DNA-PK) is a holoenzyme of three subunits, Ku70, Ku80, and 
the DNA-Pk catalytic subunit (DNA-PKcs).  DNA-PK serves a role in non-homologous end 
joining to repair double stranded breaks, and has a suggested role in the expression of base 
excision repair (BER) proteins.  Repair of DNA damage is vital to the prevention of malignant 
mutations.  Oxidative induced clustered DNA lesions (OCDLs) is the occurrence of two or more 
closely located DNA lesions, and have been shown to be poorly repaired.  DNA-PKcs is the 
phosphorylating unit of DNA-PK.  DNA-PKcs deficient cells show increased radiosensitivity 
and decreased reparability.  This study aimed to evaluate the role of DNA-PK in OCDL repair in 
DNA-PKcs deficient cells.  This study showed decreased OCDL repair and a decreased 
expression of the BER protein XRCC1 in cells treated with DNA-PKcs specific inhibitors 
compared to non-treated cells.  This study proposes that DNA-PK is involved in response to 
single and complex damage, and that inhibition of DNA-PKcs results in poor OCDL repair.  
Interest is growing in protein kinase inhibitors as supplemental aids to chemo and radiotherapies.  
This study and others indicates that DNA-PK is important to proficient DNA repair, indicating 
that DNA-PKcs inhibitors may have clinical relevance as supplemental aids to current cancer 
therapies in killing targeted cells. 
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INTRODUCTION AND BACKGROUND 
Cancer and DNA Damage 
 Despite declining cancer mortality rates in recent years, it has been estimated that last 
year half a million people in the United States died of cancer (Jemal 2009).  Environmental and 
intracellular factors contribute to genomic damage.  When un-repaired this damage can lead to 
the development of cancer (Weinberg 1996).  Cells follow a controlled pattern of genesis, 
propagation, and death.  Gene mutations, specifically mutations in tumor suppressors and 
protooncogenes can result in cells inability to properly control their cell cycle and proliferation.  
The outcome of this uncontrolled cellular proliferation is tumorogenesis.  Whether hereditary or 
occurring later in life, mutations in certain genes make cells more susceptible to becoming 
cancerous (Weinberg 1996).   
 
The ability of a cell to prevent mutagenesis and potential carcinogenesis is predicated on its 
efficiency to repair DNA damage.  Damage caused by oxidative agents and the cell’s ability to 
repair this damage has been shown to be a contributing factor in cancer development (Kastan 
2004).  Oxidative stressors can arise from internal and external sources.  As a consequence of 
internal metabolic processes oxidizing threats can occur as byproducts in the form of reactive 
oxygen species (ROS) (Neilson and Kroken 2001, Cadet 1998, and Cook 2003).  Damage by 
external factors includes chemical carcinogens such as alkylating agents and ionizing radiation 
which produces strand breaks and creates ROS as well (Lindahl and Wood 1999 and Burma 
2006, Miller 1978).  These ROS, particularly the hydroxyl radical, have the ability to oxidize 
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DNA.  The addition of an OH group to pyrimidine and/or purine bases results in improper 
molecular base structures, which can cause bond breaks resulting in strand breaks (Cadet 1998, 
and Cook 2003).  
 
 As a result of the effects of ionization and oxidation, DNA damage can be presented in the 
forms of (seen below in Figure 1) single and double stranded breaks (SSBs and DSBs), abasic 
sites, and oxidized bases (Ward 1994 and Georgakilas 2008).  These types of damage are 
proficiently repaired, but not when closely grouped (Ward 1981 and Goodheade 1994).  The 
observation of disproportionately high cytotoxicity compared to the amount of DSB damage 
following ionizing radiation prompted Ward to theorize the concept of locally multiple damaged 
sites (LMDS).  This concept linked poor repairability to the closeness of DNA damage sites 
(Ward 1981).  Clustered DNA lesions can be presented as DSBs or non-DSB oxidative clustered 
DNA lesions (OCDLs).  Studies have shown OCDLs to have poor repairability (Georgakilas 
2004).  OCDL’s as the name suggests, are lesions that appear clustered closely together, within 
10 base pairs of one another (Sutherland 2000, Francisco 2007, Gollapalle 2007).  Examples of 
DNA damage can be see below. 
Figure1.  Non-Clustered Damage 
Simple DNA Damage 
                                                
                                Oxidized Base                                                                                Abasic Site 
                                                                 
              Single Strand Break                                                                   Double Strand Break 
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Clustered DNA Lesion 
         
       Complex Base Damage                       Complex DSB                           Complex SSB 
 
Figure 2. Clustered DNA Lesions  
 
DNA Repair 
DNA damage repair is performed by various pathways. SSBs, oxidized bases and abasic sites are 
repaired through base excision repair abbreviated BER, or by nucleotide excision repair, 
abbreviated NER (Cook 2003 and Georgakilas 2008).  Damage caused as previously described, 
by low level ionization and endogenous factors are believed to be primarily repaired by BER 
(Lindahl and Wood 1999).  As seen below, BER utilizes DNA glycosylase to create an abasic 
site by indentifying and excising a damaged base.  AP-endonuclease then cleaves at the abasic 
location creating a break in the strand.  Following this, DNA polymerase is able to reinstate a 
new corrected nucleotide at the site.  DNA ligase then seals the strand (Georgakilas 2008, and 
Hada and Georgakilas 2008). 
 
 
 
Figure 3.  Base Excision Repair Pathway 
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Of greater mutagenic concern than SSBs is the occurrence of lesions that occur parallel along the 
helix, producing double strand breaks.  DSBs are considered more complex to repair, and 
therefore their occurrence is more of a threat to genomic stability (Jackson 2002).  Double strand 
breaks, depending on the phase of the cell cycle are believed to be repaired by either homologous 
repair (HR) or non-homologous end joining (NHEJ) pathways (Burma 2006 and Peddi 2008).  
OCDL’s may pose still a greater threat.  OCDL’s have been shown to be poorly repaired, if 
repaired at all, thereby eliciting increased mutagenic potential (Georgakilas 2008).  Additionally, 
as reviewed by Georgakilas, some studies suggest that glycosylase and endonuclease excising 
activities may be compromised in clustered lesion repair (Georgakilas 2008). 
Detection of DNA Damage 
The use of single cell gel electrophoresis (SCGE or Comet Assay), and pulsed field gel 
electrophoresis (PFGE) have been used for studying the processing of OCDLs by detection and 
measurement of SSBs and DSBs respectively.  Glycosylases and endonucleases are used in the 
BER pathway to induce a strand break where a corrected base can be inserted.  Based on that 
concept, bacterial DNA repair enzymes can be used to create strand breaks at oxidized base sites, 
enabling the detection and measurement of those oxidized bases (Sutherland 2000, Hada and 
Georgakilas 2008).  EndonucleaseIII repair enzymes (EndoIII) uses glycosylase activity to 
remove oxidatively damaged pyrimidines (Saito 1997).  Like EndoIII, Fpg repair enzymes use 
glycosylase activity, but to remove damaged purines (O’Conner 1992).  See Table 1 for a full list 
of base damages cleaved by Fpg and EndoIII.  Excision of bases by these enzymes creates an 
abasic (AP) site that marks the incision point for the enzyme’s abasic lyase activity to form a 
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SSB.  Simultaneous cleavage of cluster lesions on closely located opposing strands results in 
forming DSBs (Sutherland 2000).  As seen in the depiction below, the increase in detected 
breaks created by the repair enzymes at oxidized bases indicates the amount of OCDL damage 
(Sutherland 2000). 
Figure 4.  Detection of Clustered DNA Lesions  
 
Radiation: - +
Enzyme     - +    - +
DSBs
OCDL
OCDL
AP site or oxidized base
AP site oxidized base
SSB
No strand break
Neutral 
agarose gel
DSB
No detection of clusters
I IIEnzyme 
treatment
Detection of clusters
Clustered DNA Damage
1      2 3      4
-
+
 
(Hada, and Georgakilas 2008)  Detection of clustered DNA lesions (double strand breaks, DSBs and 
oxidative clustered DNA lesions, OCDL). (A) Principles of detection using a repair enzyme for a 
representative type of a cluster consisting of a set bistranded base lesions as originally introduced by 
Sutherland (Sutherland 2000). Alternatively one of the lesions can be a single strand break, SSB. As 
shown in pathway I, incomplete cleavage of both lesions by the repair enzyme will lead to no detection of 
the cluster. In the case of cleavage of both lesions by the enzyme and induction of a DSB, detection of the 
cluster occurs. (B) Detection of clusters using neutral agarose gel electrophoresis. Genomic DNA (T7 or 
λ) or human DNA can be subjected to agarose gel electrophoresis (constant or pulsed field) and with 
application of number average length analysis (NALA) the DSBs and OCDL can be measured in the same 
gel as the additional to the ones being induced by radiation. For lanes 1,2 (non-irradiated) low levels of 
endogenous OCDL are expected. For lanes 3,4 (irradiated) higher levels of OCDL are expected. 
Comparison of lane 3 and 1 will provide the yield of prompt DSBs.  (Provided courtesy of A.G. 
Georgakilas)   
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Detection and measurement of SSBs and oxidized base damage was done using a novel alkaline 
(denaturing) adaptation of the comet assay based on a previous method using DNA agarose plugs 
as in PFGE (Visvardis 2000).  The comet assay, also known as single cell gel electrophoresis 
(SCGE) or micro-gel electrophoresis, can be performed using alkaline or neutral conditions for 
the detection of SSBs (alkaline), DSBs (neutral), and oxidized bases (Hada and Georgakilas 
2008).  As reviewed by Fairbairn et al., the alkaline comet assay uses electrophoresis to force 
migration of fractured DNA by its negative ends through a gel medium. This is done under 
alkaline conditions to allow the unwinding and denaturation of DNA.  During electrophoresis the 
fragmented DNA migrates forming a tail (Fairbairn 1995).  This tail (as seen below) behind the 
cell is much like what is seen in a comet, hence the name.  The tail moment (TM) of this cell is 
proportional to the amount of damage (see below).    Oxidative damage was induced by using 
hydrogen peroxide, which has shown to induce only SSBs primarily, making it a suitable 
substitute for γ-irradiation in the study of SSB repair (Djuric 1993, and Holt and Georgakilas 
2007).  There appears to be modest research into the use of repair enzymes with comet assay to 
detect non-DSB clusters.  The inability of repair enzymes to cleave all damaged sites can result 
in clusters not being detected (Hada and Georgakilas 2008).  However, alkaline electrophoresis 
can produce breaks at any site that is alkali labile allowing for the detection of existing SSBs.  
These alkaline conditions can cause strand break formation at oxidized bases sites, such as 5,6-
dihydroxy-5,6-dihydrothymine, 5-formyluracil, oxazolone, and in oxidized abasic sites (Pouget 
2002, Douki 2006). 
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Figure 5.  Computer screenshot of a scored comet        Figure 6.  Alkaline Comet assay    
                                                                                             picture and tail moment formula 
                                               
 
 
Pulsed field gel electrophoresis was used for the first time in the early 1980’s as a solution to 
unsuccessful attempts to separate out large DNA molecules (Schwartz and Cantor 1984).  DSBs 
were shown to be measurable by PFGE using the clamped homogenous electric field (CHEF) 
technique.  CHEF uses electrophoresis at different angles surrounding a gel to force migration of 
small to large DNA fragments up to 10Mbp through a gel (Blöcher 1989).  Two or more strand 
breaks occurring within 20 base pairs of one another on opposite strands produce a DSB 
(Sutherland 1999).  PFGE or CHEF has been an effective method for the measurement of DSB 
damage and repair.  However, until nearly a decade ago no method existed to quantify the 
amount of clustered damage in large DNA fragments.  Sutherland et al., devised a method using 
repair enzymes as damage probes that cleave DNA at oxidized purines and pyrimidines creating 
SSBs at oxidized and abasic sites.  When SSBs form in close proximity on opposing strands this 
forms DSBs that can be measured using PFGE.  Using repair enzymes additional SSBs are 
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created thereby creating additional DSBs.  These DSBs are additional to the ones induced 
directly by the oxidizing agent and are equal to the number of clusters existing (Sutherland 
1999).  PFGE quantification of OCDL repair following low level γ-irradiation used treated and 
non-treated repair enzyme agarose plugs with isolated DNA.  The DNA within these plugs was 
cleaved using restriction enzymes.  The plugs were then loaded into individual wells/lanes and 
assayed using CHEF conditions.  The samples were electrophoresed through a gel medium 
alongside lanes containing standardized lengths of DNA within the expected migration 
boundaries of the samples.  The migrations of these samples provide the data needed to create a 
dispersion curve comparing DNA length with migration.  A charge coupling device (CCD) 
camera is used to fluoresce and photograph DNA.  The calculations used account for the amount 
of DNA present.  Therefore, gels were stained using ethidium bromide so the DNA fluoresced 
equaled the amount of DNA present in each sample lane (Sutherland et al. 2003).  The Software 
Quantiscan (BioSoft, Cambridge, UK) allows the amount of fluoresced DNA to be quantified.  
Using computer software in conjunction with the dispersion curve data from the DNA length 
markers, a densitogram is made for each sample lane in the PFGE gel (see below) and used to 
calculate the number average length analysis or NALA (Ln).  NALA calculations as seen below 
(Equation 1) were made for each sample comparing florescence of DNA and migration.  The 
number of DSBs for irradiated samples was found by comparing the number average length 
difference for the irradiated and non-irradiated samples (Equation 2).  Similarly, the detection 
and measurement of oxidized bases was calculated using the Ln differences of radiated samples 
with and without repair enzyme treatment (Equation 3) (Sutherland 2000).    
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Number Average Length Analysis (NALA) used in the calculations of DSBs and OCDLs 
(Equation 1)  NALA:  Ln = [ ∫ f(x)  dx ] / [ ∫ f(x) / L(x)]   
(Equation 2)  DSB Frequency = 1/Ln(Radiated) -1/Ln(Non-Radiated)  
(Equation 3)  OCDLs Frequency = 1/Ln(Radiated+Enzyme) -1/Ln(Radiated-Enzyme)  
Ln=Number average lenth, L(x)=migration distance, f(x)dx=fluorescence   (Sutherland 2000) 
 
 
 Figure 7.  PFGE Analysis.  A) Origin software (OriginLab 
Corp., MA) image of the dispersion curve of the PFGE 
standardized markers. B) Quantiscan software (BioSoft, 
Cambridge, UK) image of densitogram of an individual PFGE 
lane. C) Photographed PFGE gel showing length markers.  D) 
Photographed PFGE gel showing markers, and sample lanes 
(with and without inhibitor treatments and with differing 
repair times).  
 
 
 Samples Markers 
A) 
B) 
C) 
D) 
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DNA-PK and DNA Repair 
DNA Dependent Protein Kinase, abbreviated DNA-PK is a holoenzyme of three subunits, Ku70, 
Ku80, and DNA-Pk catalytic subunit (DNA-PKcs).  DNA-PKcs is part of the 
phospatidylinositol-3-kinases (Smith and Jackson 1999).  The Ku portions of DNA-PK are 
named Ku70 and Ku80 corresponding to their kilodalton weight (Chan 1996).  It is believed that 
the Ku heterodimer detects and attaches to the ends of double strand break sites.  To damaged 
sites, the Ku proteins recruit DNA-PKcs which is believed to help orchestrate the non-
homologous end joining (NHEJ) process by its activation of repair proteins via phosphorylation 
(Smith and Jackson 1999, Kashishian 2003, and Hudson 2005).  Studies also show repair by 
homologous recombination (HR) is decreased when DNA-PKcs expression is inhibited.  
Thereby, suggesting a possible link of DNA-PKcs in the proper induction of HR (Allen 2003).   
 
Evidence from this study and others suggests the importance of DNA-PKcs to DSB repair, 
showing increased ionizing radiation sensitivity and decreased repair in cells not expressing 
DNA-PKcs and in DNA-PKcs inhibited cells (Kashishian 2003).  Aside from the induction of 
the repair pathways, DNA-PK has been shown to be linked to cells’ ability to overcome G2 cell 
cycle arrest (Arlander 2008).  Following damage, the cell cycle may be arrested at checkpoints.  
Normally damage is repaired and the arrest is overcome.  However, in DNA-PK inhibited or 
mutated cells this arrest is much more prolonged and thereby results in higher levels of cell death 
(Arlander 2008).  
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Strand breaks are believed to interfere with the repair of nearby base lesions, thereby making 
clustered lesions difficult to repair (Dianov 2001).  SSBs and non-DSB OCDLs are believed to 
be mainly repaired by the BER pathway (Peddi 2008).  DNA-PK expression is thought to be 
involved in BER protein activation (Levy 2006, and Parlanti 2007).  One of these BER proteins 
shown to have association with DNA-PK is XRCC1 (Levy 2006).  Studies indicate that in 
response to oxidative stress, XRCC1 is stabilized/activated by DNA-PKcs phosphorylation 
(Toulany 2008).  X-ray cross-complementing or XRCC1 is a base excision repair protein shown 
to aid in decreasing radio-sensitivity and SSB repair, and is believed to function as a scaffolding 
protein (Thompson 1990, and Mourgues 2007).  Inhibition of DNA-PKcs expression therefore, 
could impede the expression of BER proteins such as XRCC1.     
DNA-PKcs Inhibitors 
Two drugs were used in this study to inhibit DNA-PKcs.  The primary drug used was 1-(2-
hydroxy-4morpholin-4-yl-phenyl)-ethanone which is called IC86621.  Created by the 
Washington based ICOS Corporation, IC86621 is an effective inhibitor of proteins in the 
phoshatidylinositol-3-kinase family, which DNA-PKcs is a member of.  IC86621 has little effect 
on related members of the phosphotidyl inositol kinase family such as ATM and ATR. 
Biochemical and genetic studies of IC86621 have demonstrated its function as a specific 
inhibitor of DNA-PK kinase activity (Allen 2003, and Kashishian 2003).   When used in 
combination with certain chemotherapeutic agents such as bleomycin there has been evidence of 
increased tumor cell death (Baily 2003, and Kashishian 2003).   To corroborate that results were 
due to DNA-Pkcs inhibition and not an unidentified supplemental feature of the IC86621, effects 
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of another novel DNA-PKcs specific inhibitor (2-(morpholon-4-yl)-benzo[h]chomen-4-one) or 
NU7026 was tested as well (Veuger 2003 and Wilmore 2004). 
Cells Studied 
 MCF-7 cells are cancerous breast cells, and are DNA-Pkcs proficient.  These cells are regularly 
used in breast cancer studies.  The original cells of this line were taken from breast cancer patient 
at the Michigan Cancer Foundation in the early 1970’s (Nugoli 2003).  MO59J and MO59K cells 
are also cancerous cells.  Both MO59J and MO59K are isogenic human glioblastoma cells that 
were taken from different areas of the same biopsy.  MO59K express DNA-PKcs, whereas 
MO59J cells are deficient for DNA-PKcs (Lees-Miller 1995, and Dibiase 2000).   Glioblastomas 
and breast cancer cells were suitable for this study because of the epidemiological significance of 
these cancers as well as the unique difference in DNA-PKcs expression of the MO59K and 
MO59J cells.  Glioblastomas are considered one of the most deadly forms of cancer, and 
unfortunately are also the most common form of central nervous system malignancies (Parsons 
2008, and Stupp 2005).  While treatable with surgical removal, chemotherapy and radiotherapy, 
the survival outlook for a majority of patients does not extend past one year following tumor 
discovery (Stupp 2005).  Due to advantages in treatment and early detection three quarters of 
those diagnosed with breast cancer now survive (Jemal 2009).  However, its rate of incidence is 
high.  Breast cancer is the most prevalent form of cancer in women worldwide.  In a 2002 
statistical study female breast cancer accounted for 31.3% of documented incidences of cancer in 
North America, and 23% worldwide (Parkin 2002).   
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HYPOTHESIS 
Various studies suggest multiple roles for DNA-PK not only in the repair of DSBs, but also other 
oxidatively-induced DNA lesions (reviewed in Georgakilas 2008).  Initial experiments using the 
cell line MCF-7 indicated that the drug IC86621 was efficient at suppressing base excision 
repair, resulting in overall deficient processing of lesions such as SSBs.  Initial experiments 
utilizing MCF-7 cells also showed reduced expression of the repair protein XRCC1 following 
IC86621 treatment.  By inducing and analyzing single strand breaks, double strand breaks, abasic 
sites and oxidized bases in DNA-PKcs deficient and proficient malignant cell lines this study 
aims to identify the role of DNA-PKcs in OCDL repair.   It is hypothesized that the chemical 
inhibition of the activity of the catalytic subunit of DNA-PK will result in compromised 
clustered lesion processing, and reduced expression of the BER protein XRCC1. 
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OBJECTIVES 
The primary objective of this study was to evaluate the role of DNA-PK in the processing of 
oxidative clustered DNA lesions in cells with proficient and deficient DNA-PKcs repair 
pathway.  MO59K human glioblastoma cells and MCF7 human breast cancer cells express 
DNA-PKcs.  To examine the role of DNA-PK in processing of clustered DNA damage, its 
kinase activity was chemically inactivated using novel inhibitors IC86621 and NU7026 in MCF7 
and MO59K cells. DNA-PKcs deficient MO59J otherwise isogenic to MO59K served as a 
control.   Damage and repair was measured using alkaline comet assay, and pulsed field gel 
electrophoresis (PFGE).  DNA-PK is postulated to have a role in BER deficiency (Levy 2006, 
and Toulany 2008).  Immunobloting was used to discern the effect DNA-PKcs expression had on 
the expression of BER protein XRCC1 post oxidative stress. 
 
Specific Objectives: 
1.  DNA-PKcs deficiencies are thought to compromise repair of single oxidativly-induced 
clustered DNA lesions.  Alkaline comet assay methods probe for SSBs.  H2O2 was used to 
induce single oxidative DNA lesions (Holt and Georgakilas 2007).  Comet assays using repair 
enzymes allowed for repair analysis of SSBs, oxidized bases, and abasic sites in DNA-PKcs 
deficient MO59J cells and in DNA-PKcs inhibited and non-inhibited MO59K and MCF7 cells. 
2.  DNA-PKcs has been shown to function in NHEJ pathway in DSB repair.  PFGE assays with 
NALA analysis were used to compare the repair of DSB and non-DSB OCDLs. This PFGE 
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repair study used DNA-PKcs deficient MO59J cells and in DNA-PKcs inhibited and non-
inhibited MO59K and MCF7 cells at incremental time points following low level γ-irradiation. 
3.  Western blotting was used in non-treated and drug treated MO59K, MO59J, and MCF7 cells 
to analyze the expression levels of the BER protein XRCC1 and it relation to the expression of 
DNA-PKcs following oxidative damage. 
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SIGNIFICANCE OF WORK 
Various risk factors associated with cancer such as heredity, environmental conditions, and life 
style has been recognized. Over the last years much has been learned about cancer etiology.  
Contributions of particular note include the delineation of the role of DNA repair factors to 
cancer risk, and especially the discovery and quantification of risks associated with gene 
mutations in DSB repair factors.  This work is original and targets for the first time the important 
role of DNA-PKcs in the processing of oxidatively induced clustered DNA damage in several 
human cancer cell lines. 
 
Although significant knowledge exists about DNA-PKcs function in the processing of double 
strand breaks, there is no knowledge currently of the effect of a compromised DNA-PKcs 
pathway in the processing of oxidatively-induced complex DNA damage. Our results provide 
evidence for a role of DNA-PKcs in the processing of different types of oxidative DNA lesions 
and suggest different mechanisms by which this effect is exerted. The information rendered by 
this novel study will be important not only for understating cancer etiology in the presence of a 
NHEJ deficiency but also lead to a better understanding of cancer treatments based on the 
inhibition of DSB repair   
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METHODOLOGY 
Cell Culture 
Three cell lines, MO59K, MO59J, and MCF-7 have been used.  MCF-7 malignant breast 
epithelial cells were acquired from the company ATCC.  The MCF-7 cells were grown in RPMI 
1640 medium.  RPMI 1640 media was attained from Gibco and contained 1 mM sodium 
pyruvate, 2 mM L-glutamine, 4500 mg/L glucose, 10mM HEPES, and 15 mg/L sodium 
bicarbonate.  In addition to the existing components, the total volume of the media was 
complemented with 10% fetal bovine serum or FBS (Invitrogen), 0.1% human insulin (Gibco).  
Cells were grown in either 25 cm2 or 75 cm2 flasks in an incubator maintaining 37˚C and a 5% 
CO2 environment.   
 
MO59K and MO59J cells were also purchased from ATCC.  The MO59J and MO59K cells were 
grown in 50:50 DMEM / F-12 (1X) with L-glutamine medium acquired from Cellgro.  DMEM / 
F-12 medium was complemented with 10% fetal bovine serum and 1% MEM Non-Essential 
Amino Acid Solution 10mM (100X) both acquired from Intvitrogen.  Like the MCF-7 cells the 
MO59J and MO59K cells were grown in 25 cm2 or 75cm2 flasks in an incubator maintaining 
37˚C and a 5% CO2 environment.  Cells were allowed to grow to between 75-85% confluency 
before being split.  Cell medium was changed generally every 4 days.   
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Alkaline Comet Assay 
Alkaline comet assays were performed using MO59K, MO59J and MCF7 cells acquired from 0, 
3, and 12 hour repair time points.  Each time point had three associated conditions, the 
conditions were (no H2O2 /with no IC86621) as the control, (no H2O2/with IC86621), and (H2O2 
treated/with IC86621).  The MO59J cells were also be used and had the same time points and 
conditions with the exception of the drug treatment.  Comet assays performed for each cell line, 
MCF-7, MO59K and MO59J each followed the same protocol.  Stock solutions of 50 mM 
IC86621 (Sigma) dissolved in dimethyl sulfoxide (DMSO) was made prior to culturing the cells 
and stored in the dark at -20˚C.  Cells were grown in 25 cm2 flasks.   
 
Once 75% confluency was reached aliquots of IC86621 in DMSO were thawed and were placed 
into the cell medium (DMEM/ F-12 for the MO59 cells and RPMI for the MCF7 cells) giving 
the medium an IC86621 concentration of 100 µM.  DMSO was then placed into the control cell 
flasks.  The control cells and the drug treated cells both have a final DMSO concentration of 
0.2%.  The cells were then allowed to incubate with the drug at 37˚C for 24 hours to allow time 
for the drug to uptake and begin inhibiting the expression of DNA-PKcs.  Following incubation 
the designated drug treated cells were treated with 100 µM H2O2 on ice for 20 minutes (Holt and 
Georgakilas 2007, Peddi 2008).  Following the hydrogen peroxide
 
treatment the 0 hour repair 
time cells were then detached from their flask using 2X Trypsin with EDTA (Trypsinization), 
and a cell count was performed.  The agarose plugs made in the comet assays contained 10,000 
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cells a piece.  Therefore, the cell counts taken were used to determine the number of plugs that 
were able to be made.   
The cells were next centrifuged, and washed with 1X phosphate buffered saline solution (PBS).  
A 50-50% solution of TE (10 mM tris-HCl, 1 mM EDTA, pH 7.5) and 1.6% low melt agarose 
was made.  Each plug consisted of 100 µl of this half TE half 1.6% low melt agarose solution.  
Therefore, the total number of cells determined how much of this solution was needed to suspend 
the pellet. (i.e. the more cells one had, the greater amount of TE/low melt agarose solution).  The 
cell pellet was suspended in the appropriate amount TE/agarose solution, then pipetted into 
plastic plug molds.  The plug molds were next placed in a 4˚C environment and allowed to 
solidify.  Once the plugs were formed they were stored at 4ºC in a pH 7.5 TE solution that had 
been argonated and supplemented with 50µM PBN to prevent free radicals.  Cells from the 3 and 
12 hours repair times were allowed to incubate at 37˚C in fresh medium containing either 100 
µM of IC86621 in DMSO or an equivalent volume of DMSO only (non-inhibited samples) for 
their respective conditions and repair times (Peddi 2008).  At the conclusion of their specific 
repair times these cells were then processed into comet assay plugs in the exact same fashion as 
described above for the 0 hour repair time cells. 
 
Following plug production cells encased in the plugs were lysed using a solution of 10% DMSO, 
1% Triton X100, and 89% Lysis solution (10 mM Tris, 100 mM EDTA, 2.5 M NaCL, pH 
10.00).  Plugs were then placed into the solution to lyse for two hours.  Assays were also 
preformed to detect Fpg or EndoIII enzyme cleavage sites, for these assays additional steps were 
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followed next.  For EndoIII, and Fpg treatments the plugs were next treated with two 30 minute 
treatments using an enzyme buffer specific for each enzyme (EndoIII buffer: 20 mM Tris-HCl, 1 
mM EDTA, pH=8.00) (Fpg buffer: 10 mM Tris-HCl, 10 mM MgCl2, pH 7.00) at 4ºC.  Plugs 
were placed in a solution consisting of 1% 100X DTT, 1% Enzyme (either EndoIII of Fpg at 
0.25 units/uL both purchased from New England Biolabs), and 98% Enzyme buffer (same as 
aforementioned enzyme buffers).  The plugs were then incubated in this solution for one hour at 
4˚C then another hour at 37˚C.   
 
Next, standard plugs and enzyme treated plugs both were placed into electrophoresis buffer (300 
mM NaOH, 1 mM EDTA, pH 12.89) for 45 minutes, then fixed to agarose frosted glass 
microscope slides using 0.8% low melt agarose solution in TE.  Slides were placed at 4˚C for 15 
minutes or until the plug is fixed to the slide. The slides were next placed into an electrophoresis 
running apparatus in electrophoresis buffer and allowed to equilibrate for 15 minutes, and then 
electrophoresed at 0.7 volts/cm and 300 mAmps for 30 minutes at 4˚C.  Slides were next washed 
in neutralizing solution (0.4 M Tris-HCl, pH7.5).  The neutralizing step consisted of 3 separate 
washes of 5, 5 and 15 minutes.  To lessen drying time, slides were then placed in 70% ethanol 
for 10 minutes then placed in a darkened room inside a ventilation hood.  Plugs were allowed to 
dry overnight.   
 
So that cells would be visible under fluorescent light, plugs were stained with 10 µM of 1X 
SybrGreen acquired from Canbrex Bioscience, and cells were photographed using an Olympus 
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BX40 fluorescent microscope with camera.  Approximately 100 cells were photographed at 20X 
magnification.  Analyzation of the cells single strand breaks as determined by tail moment was 
performed by uploading photographs into CometScoreTM software program (Tritek Corp., VA).  
This program allowed the DNA damage and repair to be quantified and compared based off of 
the tail moment of the cells, which is the tail length multiplied by the percent of fluoresced DNA 
in tail.   
Cell Lysis for Protein Lysates  
Cell lysis procedures were done the same for each cell line.  However, for MCF7 cells and for 
the MO59J and K cells different cell culture mediums were used. The difference in these 
conditions was previously described.  Cells were detached using 2X Trypsin with EDTA, and 
fresh media was added to deactivate the trypsin.  The contents of the flask were then be 
transferred into a 15 mL falcon tube and centrifuged at 2000 RPM for 5 minutes, forming a 
pellet.  The supernatant was then poured off and the pellet was then re-suspended in 1 mL of 
fresh medium, and transferred into a 1.5 mL centrifuge tube.  The tube was then centrifuged at 
12RCF for 10 minutes, and then its supernatant was removed.  The pellet was then washed with 
1X phosphate buffered saline (PBS) and centrifuged for 5 minutes at 12RCF, this was done 
twice.   
 
The supernatant was again be removed off the pellet and a lysis solution of 90 µL nuclear 
extraction buffer (2 mM EDTA, 10% sucrose, 50 mM Tris HCL, 1 mM DTT, 20% glycerol, 0.5 
mM NaCl), 3 µL PMSF, and 7 µL protease inhibitor cocktail was placed into the centrifuge tube, 
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vortexed, and allowed to incubate on ice for 30 minutes (Peddi 2008, and Francisco 2008).  The 
cells were then sonicated using 3 short bursts and then using a small scoopula, cells were mixed 
and crushed against the sides of the tube.  Cells were then centrifuged again for 30 minutes at 12 
RCF in a 4ºC cold room to prevent heat degradation of proteins (Peddi 2008, and Francisco 
2008).  Supernatant containing the cellular proteins was pipetted off and stored in a new 
centrifuge tube at -20˚C.   
Western Blot 
Prior to performing western blotting, the protein concentration of the cell lysates was found by 
performing a Bradford assay using standardized protein concentration kit (BioRad).   Whole cell 
protein samples loaded into the gels will contain normally between 20-40 µg of protein, each 
sample in a respective gel always contained equal amounts of protein.  Protein lysates were 
combined with 2X loading buffer (2.5% SDS, 5% beta-mercampoethanol) and boiled together 
for 10 minutes, and followed by one minute on ice before loading.  The volume of lysate needed 
varied depending on their concentration.  Discontinuous sodium dodecyl sulfate polyacrilimide 
gel electrophoresis (SDS PAGE) was carried out using 4-20% Tris-HCl precast gels (BioRad) 
and MiniProtean 3 cell electrophoresis device (BioRad).  The molecular weight marker 
Kaleidoscope (BioRad) was loaded into un-used well in the gel.  The electrophoresis was 
performed for 90 minutes at 180 volts and 70 mAmps at 4˚C.  Following SDS PAGE, the 
proteins and their position with the gel was transferred to a Polyvinylidiene diflouride (PVDF) 
membrane (Millipore).  PVDF membrane was cut in a size matching that of the gel, then 
activated by a 20 second washing in methanol, and then followed by a 2 minute wash in ddH2O.  
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The membrane along with filter paper (BioRad), sponges, and gel were allowed to equilibrate in 
transfer buffer (25 mM Tris-base, 192 mM glycine, pH 8.3) for 15 minutes prior to the transfer 
process.  These items were then clamped together and placed into a Mini-Trans Blot Cell transfer 
device (BioRad) and the transfer will be performed at 90 volts and 350 mAmps for 480 minutes 
at 4˚C.  
The membrane was again soaked in 100% methanol and allowed to dry.  The membrane was 
then be soaked in a blocking buffer of 5% non fat milk in 1X Tris buffered saline with tween 
(TBST) for one hour at room temperature, and briefly washed in TBST.  The membrane was 
then incubated overnight on a slow rocker at 4ºC in solution of 2.5% non fat milk in TBST 
containing monoclonal mouse antibodies specific for XRCC1 (Abcam) at a 1000:1 ratio along 
and Beta-Actin antibody (Ambion) at a 3000:1 ratio.  Membrane was then washed for one hour 
with TBST, and with 6 changes.  The secondary antibody solution consisted of 100% TBST and 
the secondary goat anti-mouse antibody (Thermo Scientific) was placed in at a 500:1 ratio.  The 
membrane was allowed to soak in the secondary antibody solution at room temperature for one 
hour under slight agitation, and was then washed as before for one hour in TBST.  Equal 
amounts of SuperSignal West Dura stable peroxidase and luminal enhancer solution (Thermo 
Scientific) were mixed together and pipetted over the membrane.  After five minute incubation at 
room temperature, the membrane was drained of any excess solution and sealed in plastic-wrap.  
Using a FlourChemTM 8800 imaging system (Alpha Innotech, San Leandro, CA) an image was 
acquired.  
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Pulsed Field Gel Electrophoresis 
Pulsed field gel electrophoresis (PFGE) like alkaline comet assay, required the creation of 
agarose plugs containing suspended cells.  The production of these plugs was done in a similar 
fashion as previously described.  The difference in the plug production was the number of cells 
used.  For PFGE 200,000 cells were needed per plug to assure that an adequate amount of DNA 
was present in each sample (Tsao 2007, Peddi 2008, and Francisco 2008).  Again DNA-PKcs 
inhibition was studied using inhibiting drugs on the MO59K and MCF7 cells.  MO59K cells 
were treated with 100 µM of IC86621 in an identical fashion to the IC86621 treatments 
described in the comet assay section (Peddi 2008). However, for the MCF7 cells a different 
DNA-PKcs inhibitor was be used.  MCF-7 cells were treated with 10 µM NU7026 (Sigma), both 
cell lines incubated at 37ºC and 5% CO2 in their respective inhibitors for 24 hours prior to 
irradiation.  Cells were transported on ice to the Brody school of Medicine.  Using the 
Gammacell 40 (MDS Nordion, Kanata, Ontario, Canada) the cells were exposed to 5Gy of 137Cs 
γ irradiation (Tsao 2007, Peddi 2008, and Francisco 2008).  Post irradiation, 0.5 M EDTA was 
pipetted into initial (0 hr) sample flasks, and all flasks were placed back on ice.  Flasks were 
placed back at 37ºC and 5% CO2 conditions until their respective repair times were reached. 
 
The production of multiple samples required many cells.  Approximately two million cells were 
needed per flask so that multiple plugs could be made.  After trypsinization, cells were counted 
and centrifuged at 2000 rpm’s for 5 minutes to form a pellet.  The pellet’s supernatant was 
removed, and to cease any reactions again 0.5 M EDTA was pipetted onto the sample.  The 
pellet was then suspended in 1.6% low melt agarose.  The amount of agarose used was calculated 
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so that each plug made possessed 200,000 cells.  Once suspended, the cells in low melt agarose 
were pipetted into plug forming plastic molds and allowed to solidify at 4˚C.  At this point the 
plugs were stored at 4ºC in a storage buffer of argonated TE pH 9 and containing 50 µM PBN.   
The plugs were next placed into 2 one hour soaks in fresh TE buffer pH 7.5.  To lyse the cells 
within the plug, the plugs were next placed into a PFGE lysing buffer (100 mM EDTA, 20mM 
NaCl, 10 mM Tris-HCl, at pH 8.3) supplemented with 1.5% n-lauaroylsarcosine, and 2% 
proteinase K for two hours on ice then the incubated at 37˚C for 24 hours.  This was repeated for 
each sample three times (Peddi 2008).  Therefore, for 3 days the plugs were transferred into new 
solution each day then re-incubated.  After the three day lysing the lysing solution was removed 
and the cells were washed for one hour with a solution of 40 mg/ml of phenylmethylsulfonyl 
fluoride (PMSF) in NTE buffer ( 150 mM NaCl, 10 mM Tris-HCl, and 0.1 mM EDTA, at pH 8).   
Next the NTE was removed and Asc-1 buffer (20 mM Tris-acetate, 10 mM magnesium acetate, 
and 50 mM potassium acetate, at pH 7.9) was pipetted onto the plugs.  The Asc-1 solution was 
changed out every 20 minutes for an hour then the plugs were incubated at 4˚C for 24 hours in 
the Asc-1 buffer.  Each sample plugs were then placed into centrifuge tubes of 300 µL of fresh 
Asc-1 buffer, and 3 µL of 100X DTT and 5 units ASC -1 enzyme.  The tubes were then 
incubated at 37˚ for 16 hours, after which 2 additional units of ASC-1 were added.  Following 
ASC-1 treatments, the plugs had three 20 minute washes in a stop solution of 70 mM Hepes-
KOH, 100 mM KCl, and 100 mM EDTA, at a pH of 7.6 (Peddi 2008).  At this point the plugs 
were ready to be either stored again or used for PFGE DSB analysis.  However, for the plugs 
used to test for enzyme repair sites, additional enzyme treatments were added.   
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For repair enzyme treatment plugs, the previous solution was removed and the plugs were 
allowed to incubate in the specific repair enzyme buffer for one hour (either Endonuclease III or 
Fpg).  During this incubation period an enzyme working solution (1unit/µl of enzyme, 18 µl of 
enzyme buffer, 3 µl of 100X DDT) was made.  The plugs were then placed into the working 
enzyme solution for an hour at 4ºC and then 65 minutes at 37˚C.  The plugs were again given 
three separate washes in the stop solution of  70 mM Hepes-KOH, 100 mM KCl, and 100 mM 
EDTA, at a pH of 7.6 for one hour, and then followed by an hour wash in TE buffer, and a wash 
in 0.5X TBE (45 mM Tris base, 45 mM boric acid, and 1 mM Na2-EDTA, pH 7.8) (Peddi 2008).   
Using a scalpel the plugs were cut so that they could be placed into the wells of the gel that were 
used in the pulse field device.  The pulse field chamber was filled with 0.25X TBE running 
buffer.  The PFGE process used two separate cycles.  The first cycle was set at 3 volts and lasted 
for 48 hours.  The second cycle which immediately followed the first was set at 6 volts and 
lasted for five hours.  Following this the gel was removed and then stained by soaking it in 1 
µg/ml ethidium bromide (20 µl/200 ml) for 15 minutes with slight agitation. The gel was then 
washed with distilled water overnight.  Using a FlourChem 8800 imaging system (Alpha 
Innotech, San Leandro, CA) a photograph of the PFGE gel was taken.  The images taken were 
analyzed using the software Quantiscan (BioSoft, Cambridge, UK), and NALA calculations 
(Tsao 2007, Peddi 2008, Sutherland 2000).  This software and NALA calculations as previously 
described allowed for numeric comparisons of DNA repair between the differing conditions.      
Statistical Significance 
Paired Students T-tests was used to evaluate differences between averages of different groups 
(P<0.05). 
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RESULTS 
Measurement of single DNA lesions 
Alkaline comet assay was used to evaluate the role of DNA-PKcs in single DNA lesion repair.  
Repair of these lesions was studied following oxidative damage (H2O2 exposure) using IC86621 
treated and non-treated MO59K and MCF7 cells, and MO59J cells as well (Figures 8-13).  
Alkaline comet assay methods in conjunction with CometScoreTM software (Tritek Corp., VA) 
was use to examine tail moments (TM) in cells being studied (See Figure 23 for photographic 
examples).  Figures 8-10 show the study of repair in IC86621 treated and non-treated MO59K 
and MO59J cells following H2O2 exposure.  Figures 11-13 show the study of repair in IC86621 
treated and non-treated MCF7 cells following H2O2 exposure.  Figure 11 shows the processing of 
SSBs was not affected in IC86621 treated MCF7 cells compared to non-treated MCF7cells.  
However, as can be seen in figure 8, compared to non-treated MO59K cells, the IC86621 treated 
MO59K cells showed a decrease in SSB repair, as did MO59J cells (*; p<0.05).  Following H2O2 
exposure, use of EndoIII and Fpg repair enzyme treatments resulted in greater TM at initial times 
(Figure 9-10 and 12-13).  Inhibitor treated MO59K and MCF7 cells, and MO59J cells showed 
deficient processing of Fpg and EndoIII sites.  In comparing EndoIII and Fpg sites it was seen 
EndoIII damaged sites were more common at the initial time for all cell lines.  This suggested 
improperly functioning BER, and/or that H2O2 exposure mainly causes oxidized pyrimidines. 
Immunoblotting of XRCC1 expression 
Immunoblots seen in figures 14-16 show the measured expression of the BER protein XRCC1 
following H2O2 oxidative damage in IC86621 treated and non-treated MCF7 and MO59K cells, 
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and in MO59J cells as well.  Beta-Actin was used as a loading control.  XRCC1 expression 
levels were decreased in cells whose DNA-PKcs activity was inhibited using IC86621 (see 
Figures 14 and 16).  Since XRCC1is a BER protein (Kashishian 2003) this corresponds with the 
poor repair of single lesions seen in the DNA-PKcs inhibited cells.  MO59J cells which do not 
express DNA-PKcs had reduced XRCC1 expression as well.  However, the reduction in XRCC1 
expression was not as prominent in the MO59J cells as it was in the IC86621-treated MO59K 
cells.  Basal levels of XRCC1 expression were increased in DNA-PKcs inhibited cells (Figure 
14, lanes 3 and 4).  However, as seen in lanes 2 and 4 of Figure 15, the basal level of XRCC1 in 
the MO59J cells was lower than the basal XRCC1 level seen in MO59K cells, conferring with 
studies by Toulany et al. (Toulany 2008)     
Measurement of DSB and OCDL Repair 
The NHEJ pathway functions to repair DSBs, and DNA-PK is an important part in that pathway 
(Burma 2006, Hudson 2005, Peddi 2008, Smith & Jackson 1999).  PFGE in combination with 
base repair enzymes and NALA calculations were used to study whether DSB and/or OCDL 
repair following 5Gy irradiation was impacted by DNA-PKcs deficiency.  To do this MCF7 and 
MO59K cells were studied with and without treatments of kinase inhibitors specific for DNA-
PKcs.  MO59K cells were treated with the inhibitor IC86621, and MCF7 cells were treated with 
the inhibitor NU7026.  MO59J cells were used in the study as a control alongside MO59K cells.  
MO59J cells do not express DNA-PKcs, making them less efficient in DSB repair.  However, 
except for this non-expression of DNA-PKcs, MO59J cells are otherwise isogenic with MO59K 
cells (Lees-Miller 1995, and Dibiase 2000). 
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Over incremental repair times (0, 1, 6, 12, 24, 48 hrs) NU7026-treated MCF7 and IC86621-
treated MO59K cells showed significant persistence of DSB compared to their controls (see 
Figures 17 and 20).  The number of DSBs was consistently significantly greater for repair times 
between 6 to 24 hours post irradiation for inhibitor treated MO59K and MCF7 cells compared to 
their non-inhibitor treated controls.  Even though not statistically significant, the IC86621-treated 
MO59K cells continually showed a greater DSB accumulation than the MO59J cells.  In all 
experimental cells, DSBs still present 24 hours following irradiation suggests DNA-PKcs 
deficiencies are resulting in the DNA not being fully rejoined.  
 
Quantification of clustered lesions studied using PFGE can be seen in Figures 18-19 and 21-22.  
Significant differences in repair between 6-48 hours (p<0.05) were detected between non-
inhibitor treated controls and DNA-PKcs deficient cells (IC86621-treated MO59K, NU7026-
treated MCF7, and MO59J).  As was the case with DSB damage, the IC86621-treated MO59K 
cells had a greater accumulation of clustered damage than the MO59J cells, but not a statistically 
significant difference (Figures 18-19).  In all inhibitor treated cells, OCDLs did not return to 
background levels before the final time point (Figures 18-19 and 21-22).  A similar trend is seen 
in figures 18 and 19 for MO59J cells. 
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DISCUSION 
The goal of this study was to examine the involvement of DNA-PK in repair of non-DSB 
clustered oxidative DNA damage.  Results of this study and others have shown that DNA-PKcs 
deficiencies are in fact associated with poor DSB and non-DSB lesion repair.  NHEJ and BER 
have been shown to function in the repair of non-DSB OCDLs (Hashimoto 2001, Malyarchuk 
2008, and Pedi 2008).  DNA-PKcs chemical inhibition with highly specific drugs shown to target 
exclusively the DNA-PKcs kinase activity was used on DNA-PKcs proficient cells (Baily 2003 
and Kashishian 2003, and Wilmore 2004).  Repair was measured and compared between 
differing conditions and cells following oxidative stress.  Oxidative damage was induced using 
low level irradiation for PFGE studies, and H2O2 exposure in alkaline comet assay studies.  
Western blotting was also performed to evaluate the effect DNA-PKcs expression has on the 
expression of the BER repair protein XRCC1.  The malignant MO59K and MCF7 cells had 
normal DNA-PKcs expression.  Alongside the studies for these cells, MO59J cells deficient in 
DNA-PKcs were used, and served as a control and a comparison for the drug treated cells.   
 
Single strand break analysis as seen from figures 8 and 11, showed decreased repair in both drug 
treated MCF7 and MO59K cells following H2O2 exposure.  MO59J cells also showed decreased 
repair similar to that observed in the drug treated MO59K cells.  The lack of SSB repair observed 
in MO59J and drug treated MO59K cells compared with the effective SSB processing seen in 
normal MO59K cells indicate the use of DNA-PK functioning in the BER pathway, and the 
inhibiting effects of IC86621.   Figures 9-10 and 12-13 also showed decreased EndoIII and FPG 
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enzyme site repair in cells with inhibited or deficient DNA-PKcs.  All figures showed a large and 
significant increase in tail moment with the addition of H2O2 indicating the effectiveness of H2O2 
in creating single strand and oxidized base damage.  Repair was observed at 0, 3, and 12 hours 
post induced oxidative damage.  A greater tail moment is seen for repair enzyme treated cells for 
figures 9-10 and 12-13, indicating the presence of endogenous oxidized base damage.  Figure 11 
also shows very low SSB basal damage for MCF7 cells compared to the MO59K and MO59J 
cells indicating less endogenous SSBs in MCF7 cells.  The fact that all cell lines showed a 
greater propensity for endogenous oxidized damage compared to SSB indicated that oxidized 
bases may be the more common form of endogenous damage.  As can be seen by comparing fig 
11 with figures 12-13 this disparity between endogenous SSBs and oxidized base damage was 
much more evident in MFC7 cells.  In comparing oxidized base repair with the processing of 
SSBs using the MCF7 cells the DNA-PKcs inhibited cells showed limited processing ability of 
damaged repair enzyme sites.  The disproportionately poor enzyme site repair compared to SSB 
seen in the MCF7 cells (figures 11-13), indicates that although DNA-PKcs plays some role in 
SSB repair it may be of significant importance in the repair of oxidized bases and abasic sites.    
 
The decrease seen in SSB processing efficiency in DNA-PKcs inhibited or absent cells 
implicates it as a possible activator of known BER proteins.  XRCC1 is a BER protein 
previously believed to associate with DNA-PK (Thompson 1990, and Mourgues 2007).  To 
study DNA-PK’s role in BER proteins, XRCC1 was chosen.  Whole cell lysates of MO59J cells, 
and MO59K and MCF7 cells both treated and non-treated with IC86621 were made following 
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oxidative damage.  As seen in figures 14-16 although XRCC1 expression is present in all 
samples.  Figures 14 and 16 show that the expression of XRCC1 is decreased in IC86621 treated 
samples.  Figure 15 shows this is also the case in cells absent for DNA-PKcs.  Studies have 
shown that XRCC1 expression levels following damage may be related to the base expression of 
XRCC1 in undamaged cells, and that cells with low basal expression have larger increases in 
XRCC1 expression following oxidative damage (Toulany 2008).  It is believed that DNA-PK 
does not activate XRCC1 production, but either stabilizes or activates and regulates present 
XRCC1 in response to oxidative damage (Toulany 2008).  It cannot be ruled out that DNA-PKcs 
has some effect on synthesis of new XRCC1.  However, studies have shown that the quick 
induction of XRCC1 following damage indicates a stabilizing or activating role of DNA-PKcs 
(Toulany 2008).   XRCC1 has shown to be quickly degraded by the ubiquitin-protease pathway 
and that the protein JWA stabilizes XRCC1 by blocking ubiquilyation sites (Wang 2009).  It is 
possible that DNA-PKcs could serve a similar role or even have some function with JWA or 
proteins like it to stabilize XRCC1.  None the less, studies have implicated XRCC1 as vital in 
base lesion repair (Mourgues 2007).  The decreased XRCC1 expression in the blot samples 
deficient in DNA-PKcs coupled with the decreased processing of repair enzyme sites seen in 
figures 9-10 and 12-13 help to give credence to XRCC1’s role in base lesion repair.  This 
additionally provides a possible expiation for the poor repair seen in the enzyme treated samples.      
 
Double strand break analysis was performed on post 5Gy γ-irradiated MO59K, MO59J, and 
MCF7 cells with identical drug treatment conditions used in the SSB studies previously 
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described.  Similar differences were seen in DSB repair analysis (figures 17-22).  Again there 
appeared to be decreased repair in DNA-PKcs inhibited/absent.  DSBs are more complex to 
repair than single lesions (Jackson 2002). Unlike the SSB results (Figures 8-13) this difference in 
repair between the samples is not significant until time points of six hours or more.  Notice that 
at initial time points all samples of each condition show similar amounts of damage, and that by 
the final time point all cells expressing DNA-PKcs have nearly returned to basal levels of 
damage.  Repair ability appears to be decreased for oxidized base lesions particularly for Fpg 
sites.  As seen in figure 19, not only did the DNA-PKcs inhibited/absent cells have decreased 
repair, their number of DSBs resulting from oxidized purines increased in the final hours.  
Considerably less efficient repair in the drug treated MO59K and MO59J cells was seen 
compared to non-treated MO59K cells.  To ensure the decreased repair was due to DNA-PKcs 
inhibition and not solely a novel attribute of IC86621, another DNA-PKcs inhibitor (NU7426) 
was used with the MCF7 cells.  As seen in figures 20-22, again a decreased ability to processes 
DSB’s is seen in the drug treated samples.  Again the initial time point shows that the cells had a 
similar damage response to the irradiation treatment and that by the final time point the untreated 
samples had nearly returned to their basal level, whereas the drug treated samples still possessed 
much unprocessed damage. 
  
The decrease in DSB and base lesion repair efficiency adds to the evidence suggesting that 
DNA-PK has a role in the NHEJ and HR (Hashimoto 2001, Malyarchuk 2008, Allen 2003).  It 
also indicates poor OCDL repair in response to DNA-PK deficiencies.  Interestingly, the 
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decreased repair efficiency seen in drug treated MO59K cells was greater than the decrease seen 
in the MO59J cells.  These differences suggest that the inhibitor may affect proper functioning of 
other repair pathways that are allowed to operate in MO59J cells.  Drugs such as IC86621 do not 
inhibit the production of DNA-PKcs, but inhibit its kinase ability.  Therefore DNA-PKcs is still 
able to be recruited to damaged sites, but unable to dissociate (Meek 2007, Meek 2008, 
Shrivastav 2008).  As time progresses damage continues to be repaired.  This repair is slowed in 
DNA-PKcs deficient cells and even more delayed in DNA-PKcs inhibited cells.  This data, 
coupled with current knowledge of the role of DNA-PK in repair, indicates different models may 
exist for complex DNA damage repair (figure 24).  
  
This study helps to better understand the role of DNA-PK in the repair of clustered DNA lesions.  
Results from SSB, DSB and abasic site repair analysis indicate that cells with inhibited or absent 
DNA-PKcs exhibit compromised lesion repair.  These results indicate the possible employment 
of DNA-PK in the functioning of different repair pathways.  Proteins kinases help regulate the 
cycle and proper maintenance of cells including their genomic repair (Fabbro 2002 and 
Kiahishian 2003).  With various protein kinases having been linked to genes important in cancer 
prevention, the research of protein kinase inhibition in cancer treatment is a growing field of 
study (Fabbro 2002).   Many cancer treatments induce DNA damage to levels lethal to cells.  
Therefore, for those targeted cells less efficient repair would be preferred.  This and other studies 
have shown that DNA-PKcs inhibition results in poor DNA repair, and increases cell sensitivity 
to radiotherapy and chemotherapeutics such as Bleomycin.  Thus, suggesting possible benefits of 
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DNA-PKcs inhibition in cancer treatments (Kashisian 2003).  This study shows that using 
chemical inhibition of DNA-PKcs in malignant tumor cells results in a decrease in the cells 
ability to repair damage.  These results indicate the importance of DNA-PK in the repair of 
DNA, and therein its role in maintaining genomic integrity.        
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Figure 8.  The effect of DNA-PKcs inhibition in the repair of SSBs.  SSB repair in IC86621 and 
H2O2 treated MO59K cells and regular MO59J/K cells and control following 15 min exposure to 
100 µM H2O2.  The control with no H2O2 and no IC6621 is included.  SSB detection at 0, 3 and 
12 hrs following damage using alkaline single cell gel electrophoresis (comet assay).  Values are 
averages from 3 independent experiments. Statistically significant differences between IC86621 
treated MCF7 cells and controls at p<0.05 are depicted by (*). 
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Figure 9.  The effect of DNA-PKcs inhibition in the repair of oxidized bases.  Repair of oxidized 
pyrimidines in IC86621 and H2O2 treated MO59K cells and regular MO59J/K cells and control 
following 15 min exposure to 100 µM H2O2.  The control with no H2O2 and no IC86621 is 
included.  EndoIII site detection at 0, 3 and 12 hrs following damage using alkaline single cell 
gel electrophoresis (comet assay).  Values are averages from 3 independent experiments. 
Statistically significant differences between IC86621 treated MCF7 cells and controls at p<0.05 
are depicted by (*). 
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Figure 10.  The effect of DNA-PKcs inhibition in the repair of oxidized bases.  Repair of 
oxidized purines in IC86621 and H2O2 treated MO59K cells and regular MO59J/K cells and 
control following 15 min exposure to 100 µM H2O2.  The control with no H2O2 and no IC86621 
is included.  Fpg site detection at 0, 3 and 12 hrs following damage using alkaline single cell gel 
electrophoresis (comet assay).  Values are averages from 3 independent experiments. 
Statistically significant differences between IC86621 treated MCF7 cells and controls at p<0.05 
are depicted by (*). 
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Figure 11.  The effect of DNA-PKcs inhibition in the repair of SSBs.  Single lesion repair in 
IC86621 and H2O2 treated MCF7 cells and controls following 15 min exposure to 100 µM H2O2.  
The control with no H2O2 and no IC6621 is included.  SSB break detection done at 0, 3 and 12 
hrs following damage using alkaline single cell gel electrophoresis (comet assay).  Values are 
averages from 2 independent experiments. Statistically significant differences between IC86621 
treated MCF7 cells and controls at p<0.05 are depicted by (*). 
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Figure 12.  The effect of DNA-PKcs inhibition in the repair of single oxidative DNA lesions.  
Oxidized pyrimidine repair in IC86621 and H2O2 treated MCF7 cells and controls following 15 
min exposure to 100 µM H2O2.  The control with no H2O2 and no IC6621 is included.  EndoIII 
site detection at 0, 3 and 12 hrs following damage using alkaline single cell gel electrophoresis 
(comet assay).  Values are averages from 2 independent experiments. Statistically significant 
differences between IC86621 treated MCF7 cells and controls at p<0.05 are depicted by (*). 
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Figure 13.  The effect of DNA-PKcs inhibition in the repair of single oxidative DNA lesions.  
Oxidized purine repair in IC86621 and H2O2 treated MCF7 cells and controls following 15 min 
exposure to 100 µM H2O2.  The control with no H2O2 and no IC6621 is included.  Fpg site 
detection at 0, 3 and 12 hrs following damage using alkaline single cell gel electrophoresis 
(Comet Assay).  Values are averages from 2 independent experiments. Statistically significant 
differences between IC86621 treated MCF7 cells and controls at p<0.05 are depicted by (*). 
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Figure 14.  Western blot detection of XRCC1 in IC86621 treated MCF-7 cells 30 min following 
100 µM H2O2 exposure. Each lane contained 40 µg of protein. Lane 4 (MCF7 with DMSO) 
served as control.  β-actin was used as a loading control.  Values were normalized to the control 
and shown as the ratio of XRCC1/actin.  
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Figure 15.  Western blot detection of XRCC1 in IC86621 treated MO59J/K cells 30 min 
following 100 µM H2O2 exposure. Each lane contained 40 µg of protein. Lane 2 (MO59J with no 
H2O2) served as control.  β-actin was used as a loading control.  Values were normalized to the 
control and shown as the ratio of XRCC1/β-actin.  
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Figure 16.  Western blot detection of XRCC1 in IC86621 treated MO59K cells 30 min following 
100 µM H2O2 exposure. Each lane contained 40 µg of protein. Lane 3 (MO59K with DMSO 
only) served as control.  β-actin was used as a loading control.  Values were normalized to the 
control and shown as the ratio of XRCC1/β-actin.  
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Figure 17.  Detection of DSB damage repair using PFGE. Processing of DSBs as a function of 
time following irradiation in DNA-PKcs proficient MO59K cells and in deficient MO59J and 
IC86621 treated MO59K cells.  Averaged values from independent experiments for MO59K and 
MO59J cells were taken at 0, 1, 6, 12, 24, and 48 hrs.  In some instances SEM error bars are 
smaller than their associated symbol.  MO59K cells are Square symbols.  MO59J cells are 
circular symbols.  MO59K cells treated with IC86621 are Triangular symbols.  Statistically 
significant differences between IC86621 treated MCF7 cells and controls at p<0.05 are depicted 
by (*).     
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Figure 18.  Detection of non-DSB oxidized cluster repair using PFGE.  Processing of pyrimidine 
damage as a function of time following irradiation in DNA-PKcs proficient MO59K cells and in 
deficient MO59J and IC86621 treated MO59K cells.    Averaged values from independent 
experiments for MO59K and MO59J cells were taken at 0, 1, 6, 12, 24, and 48 hrs.  In some 
instances SEM error bars are smaller than their associated symbol.  MO59K cells are Square 
symbols.  MO59J cells are circular symbols.  MO59K cells treated with IC86621 are Triangular 
symbols.  Statistically significant differences between IC86621 treated MCF7 cells and controls 
at p<0.05 are depicted by (*).     
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Figure 19.  Detection of non-DSB oxidized cluster repair using PFGE.  Processing of purine 
damage as a function of time following irradiation in DNA-PKcs proficient MO59K cells and in 
deficient MO59J and IC86621 treated MO59K cells.    Averaged values from independent 
experiments for MO59K and MO59J cells were taken at 0, 1, 6, 12, 24, and 48 hrs.  In some 
instances SEM error bars are smaller than their associated symbol.  MO59K cells are Square 
symbols.  MO59J cells are circular symbols.  MO59K cells treated with IC86621 are Triangular 
symbols.  Statistically significant differences between IC86621 treated MCF7 cells and controls 
at p<0.05 are depicted by (*).     
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Figure 20.  Detection of DSB damage repair using PFGE. Processing of DSBs as a function of 
time following irradiation in DNA-PKcs proficient MCF7 cells and in inhibited NU7026 treated 
MCF7 cells.  Averaged values from 3 independent experiments for NU7026 treated and non-
treated MCF7 cells were taken at 0, 1, 6, 12, 24, and 48 hrs.  In some instances SEM error bars 
are smaller than their associated symbol.  Untreated MCF7 cells are square symbols.  NU7026 
treated MCF7 cells are circular symbols.    Statistically significant differences between IC86621 
treated MCF7 cells and controls at p<0.05 are depicted by (*).     
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Figure 21.  Detection of non-DSB oxidative DNA cluster repair using PFGE. Processing of 
pyrimidine clusters as a function of time following irradiation in DNA-PKcs proficient MCF7 
cells and in inhibited NU7026 treated MCF7 cells.  Averaged values from 3 independent 
experiments for NU7026 treated and non-treated MCF7 cells were taken at 0, 1, 6, 12, 24, and 48 
hrs.  In some instances SEM error bars are smaller than their associated symbol.  Untreated 
MCF7 cells are square symbols.  NU7026 treated MCF7 cells are circular symbols.    
Statistically significant differences between IC86621 treated MCF7 cells and controls at p<0.05 
are depicted by (*).     
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Figure 22.  Detection of non-DSB oxidative DNA cluster reapir using PFGE. Processing of 
pyrimidine clusters as a function of time following irradiation in DNA-PKcs proficient MCF7 
cells and in inhibited NU7026 treated MCF7 cells.  Averaged values from 3 independent 
experiments for NU7026 treated and non-treated MCF7 cells were taken at 0, 1, 6, 12, 24, and 48 
hrs.  In some instances SEM error bars are smaller than their associated symbol.  Untreated 
MCF7 cells are square symbols.  NU7026 treated MCF7 cells are circular symbols.    
Statistically significant differences between IC86621 treated MCF7 cells and controls at p<0.05 
are depicted by (*).     
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Figure 23.  Photos comparing MO59K cells treated with the DNA-PKcs inhibitor IC86621, and 
MO59K cells without IC86621.  Photos were taken following 100µM H2O2 exposure and 
electrophoresis at 0.7V/cm2 taken at 20X magnification.  Photos were taken at 0, 3, and 12 hour 
repair times showing initial damage and the decrease in tail moment as time progresses, and the 
decreased repair in drug treated cells.      
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Figure 24.  Representation of differing OCDL processing pathways based on the presence, 
absence or inhibition of DNA-PKcs activity.  Autophosphorylation of DNA-PK allows 
disassociation from the ends of DNA.  This dissociation must happen so DSB repair by NHEJ 
and HR can ensue, and then other clustered sites can be repaired normally as seen in Path I.  Path 
II shows NHEJ cannot proceed in situations of DNA-PKcs absence so other DSB repair 
pathways are utilized.  Inhibition of DNA-PKcs autophosphorylation due to chemical inhibitors 
prevents dissociation from the damaged site as seen in Path III.  In this situation repair via NHEJ 
does not occur and DNA-PKcs molecule blocks the site from being properly repaired by other 
repair pathways.  (Courtesy of A.G. Georgakilas)    
 
  
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(C
o
u
rt
e
sy
 o
f 
A
.G
. 
G
e
o
rg
a
k
il
a
s)
 
  
70 
 
Table 1.  A table listing the known oxidative base damage substrates with a repair enzyme 
known to cleave it.  Table shows the oxypyrimidines repaired by EndoIII, and the oxypurines 
repaired by Fpg  (courtesy A. Georgakilas) (Weinfeld 2001, Hada and Georgakilas 2008). 
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Repair enzymes used as damage probes Substrates 
E.coli Fpg protein or hOGG1 protein 
(DNA glycosylase)  Associated lyase 
activity 
Oxypurines: FapyAdenine, FapyGuanine,   
C8-oxoGuanine, some abasic sites, C8-
oxoAdenine, and other modified purines. 
E.coli or human Nth1 protein 
(Endonuclease III)  Associated lyase 
activity 
Oxypyrimidines: Thymine residues damaged 
by ring saturation, fragmentation, or ring 
contraction including thymine glycol and 
uracil residues. 
 
(Courtesy A. Georgakilas) (Weinfeld 2001, Hada and Georgakilas 2008) 
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